basalis and a 2 nd trimester shift towards Type 2 immunity. Decidual CD56 bright NK cells arise at least partly from circulating progenitors expressing adhesion molecules SELL and ITGA4 and the chemokine receptors CXCR3 and CXCR4. In vitro studies show that T1DM reduces interactions between blood CD56 + NK cells and decidual endothelial cells by reducing SELL and ITGA4-based interactions. To address the mechanisms by which specific lymphocyte subsets may be recruited from the circulation during pregnancy and whether these mechanisms are altered in T1DM, flow cytometry was used to examine eight peripheral blood lymphocyte subsets (Type 1 
Introduction
Type 1 Diabetes Mellitus (T1DM) significantly elevates risk for gestational complications such as premature birth, macrosomia, perinatal death and preeclampsia [1] [2] [3] [4] . These risks occur despite appropriate glycemic control [3] . Enhanced pro-inflammatory responses characterize not only T1DM [5, 6] , but also several pregnancy disorders [7] [8] [9] . During normal pregnancy, circulating and tissue-specific decidual lymphocytes contribute to conceptus tolerance, vascular remodeling and placental development [10, 11] . In early human decidua (a transient, uterine stromal cell-derived progesterone-dependent tissue), the most abundant lymphocytes are CD56 bright Natural Killer cells (NK). Decidual CD56 bright (d)NK cells secrete cytokines and
angiokines, but display limited cytotoxic ability [10, 11] . Origins of CD56 bright dNK cells and other decidual lymphocytes are unclear. The possibility that they are derived from NK cell populations recruited from peripheral blood has been suggested [12] [13] [14] [15] [16] . However, research also supports recruitment at earlier lymphocyte stages or from other tissues as well as differentiation from resident self-renewing progenitors within the uterus [17] . Adoptive transfer studies in mice support all of these possibilities [18] [19] [20] . Previous research serially comparing cells from women at days 8 or 20 in a monitored menstrual cycle showed that CD56 + blood leukocytes collected at the LH surge have enhanced in vitro adhesion to endothelium of decidua basalis under shear forces [15] . Gains in in vitro adhesion to decidual endothelium are also reported in early pregnancy and have been linked with fertility [16] . In both studies, selectin L (SELL) and alpha 4 integrin (ITGA4)-based adhesion were identified as mechanisms promoting these changes in function [15, 16] . In contrast, blood CD56 + NK cells from pregnant T1DM and T2DM women are less adherent in vitro than blood CD56 + cells from gestational age-matched normal pregnant women to decidual endothelium, and more adherent to pancreatic endothelium [21] . SELL and ITGA4 alterations accounted for 75% of the functional change in diabetic CD56 + cell adhesion to decidual endothelium, suggesting that CD56 + NK cells in diabetic women had a diabetes-associated deviation in homing potential [21] . SELL and ITGA4 are strongly expressed by circulating CD56 bright NK cells [22] and have been identified as key receptors that could direct CD56 + blood NK cell homing to the uterus [22, 23] . Leukocyte homing to specialized environments also involves interactions between tissue-secreted chemokines and leukocyte-expressed chemokine receptors [24] [25] [26] . Decidua produces abundant CXCL10 and CXCL12 [27] , chemokines that bind to CXCR3 and CXCR4 respectively. Blood CD56 bright NK cells highly express CXCR3 and CXCR4 [24] that would enable lymphocyte-decidua interactions and promote lymphocyte retention within decidua. Stability in the expression of these receptors has not been assessed over pregnancy. In the 1 st trimester of normal human pregnancy, a Type 1 immune state (also referred to as Th1 or the physiological pro-inflammatory state that normally characterizes men and nonpregnant women) is present systemically. In late 2 nd trimester, a shift towards Type 2 immunity (Th2 or anti-inflammatory state) occurs [28] [29] [30] . Here we compare the serial immune profiles (Type 1 or Type 2 immunity) and expression of selected homing receptors (ITGA4, SELL, CXCR3 and CXCR4) in blood lymphocyte subsets of normal pregnant women and T1DM women receiving regular prenatal medical care. Expression of IL18R1 or IL1RL1 was used to identify Type 1 and Type 2 lymphocytes, respectively, as previous described [30] . IL18R1 regulates IFNG [31] , an important cytokine in early decidua [32] ; as well as perforin expression in human decidual leukocytes, in vitro [33] . IL1RL1 through activation by IL33, a cytokine also expressed by early human decidua [34] , is a crucial amplifier of innate rather than adaptive Type 2 immunity [34, 35] . We hypothesized that women with T1DM would have increased Type 1 lymphocyte bias throughout gestation and altered homing receptor expression on NK cell subsets. CD56 bright NK, CD56 dim NK, NKT and CD3 + T cell subsets were examined in a cross-sectional longitudinal study that followed 7 T1DM patients and 8 age-matched controls over pregnancy and postpartum. Our outcome data show that in well-monitored T1DM women, the shift to Type 2 lymphocyte-predominance in the 2 nd trimester of pregnancy does not occur and the expression of homing receptors in blood lymphocytes is dampened compared with matched controls.
Material and Methods

Subject recruitment
Pregnant Caucasian women with T1DM (n = 7) and healthy, racially and age-matched controls (n = 8) were recruited at Kingston General Hospital (Kingston, ON, Canada). The T1DM women used insulin pumps and regularly visited the diabetic pregnancy clinic for supervised care. Exclusion criteria were multiple pregnancy, previous diagnosis or treatment of hypertension, polycystic ovarian syndrome, cancer and/or autoimmune disease other than T1DM. Patients provided a written consent and were free to withdraw at any time without any impact on their care. All patient samples were coded and blinded to investigators and no personal identifying information was recorded for study purposes. Flow cytometry 5 x 10 5 cells/mL in 50μl of PBS containing 1% Bovine Serum Albumin (BSA) and 2% heat-inactivated human male serum were labeled using directly conjugated monoclonal antibodies and isotype controls. The antibodies and isotype controls, as well as the staining strategy are summarized in S1 Multiplex cytokine/chemokines/growth factor microbead immunoassay A multiplex biometric immunoassay, containing fluorescent microspheres conjugated with a monoclonal antibody specific for a target protein, was used for cytokine measurement according to the manufacturer's instructions (Bio-Plex Human Cytokine Assay # M50-0KCAF0Y; Bio-Rad Inc., Hercules, CA, USA). For this assay, six patients from the control group had plasma available. All seven plasma samples from T1DM patients were tested in this assay.
Statistical analyses
Demographic data for subjects used in the flow cytometric analyses are presented as means ± SEM, unless otherwise specified, and compared by t-test. Lymphocyte subset data are presented as a percentage of total lymphocytes or percent positive of specified subset. Some data were log transformed to normalize their distribution and permit statistical analyses. Flow cytometry data were subjected to Grubb's test to exclude outliers, followed by analysis between groups using two-way ANOVA with Bonferroni's post-test. This was followed by one-way ANOVA with Bonferroni's or Dunn's post-tests, as applicable. To determine the impact of two T1DM patients who were diagnosed with preeclampsia after donation of their 3 rd trimester sample, analyses were repeated (as described above) excluding these patients from the T1DM group. The data from multiplex biometric immunoassay were tested for the normality using Shapiro-Wilk test, and compared using the Mann Whitney-U test. Data were analyzed using Prism 5 Statistical Software package (GraphPad, San Diego, CA, USA). P values of <0.05 were considered statistically significant.
Results and Discussion
Patient demographics
Maternal demographics and clinical data are presented in Table 1 . Two T1DM patients developed preeclampsia after donation of their 3 rd trimester sample. Both patients donated postpartum samples. The systolic blood pressure of T1DM patients was significantly higher than controls and the T1DM patients delivered preterm. Despite receiving regular pre-natal care at 1A) . The proportions of NK CD56 bright , NK CD56 dim , NKT and T cells were invariant across pregnancy and postpartum and were not significantly different between control and T1DM patients (Fig. 1B) . Type 1 vs Type 2 lymphocyte ratios across control and T1DM pregnancies i) Global lymphocyte analyses. IL18R1 and IL1RL1 were used as surface molecules to identify Type 1 and Type 2 biased lymphocytes, respectively [30, 31] and the ratio of Type 1/ Type 2 lymphocytes was calculated. The Type 1/Type 2 lymphocyte ratios for control patients were highest in 1 st trimester and declined in later trimesters and postpartum (P = 0.0065; Fig. 2 ). The decline was driven by an increase in Type 2 lymphocytes. This shift of immunity from Type 1 (1 st trimester) towards Type 2 in later gestation is similar to data reported by others for normal human pregnancies [29, 30] . In contrast, for T1DM patients, Type 1/Type 2 total lymphocyte ratios were invariant across pregnancy and postpartum (Fig. 2) . Thus, no Type 2 immune shift occurred during pregnancy in T1DM patients. ii) Lymphocyte subset analyses. Type 1/Type 2 ratios were also calculated for each lymphocyte subset as described below (Fig. 4A-D) . Fig. 4B ). In T1DM patients, no alterations occurred. No significant differences were found between control and T1DM patients for any pregnancy or postpartum period (Fig. 4B) . CD3 + CD56 + NKT cells: Type 1/Type 2 ratios did not differ across pregnancy and postpartum in either patient group or between patient groups (Fig. 4C) . Thus, the Type 1/Type 2 NKT cell ratio in blood is not influenced by either pregnancy or T1DM. CD3 + CD56 -T cells: In control patients, the Type 1/Type 2 ratio expressed by T cells was lower in 2 nd compared to 1 st trimester (P<0.05), consistent with a shift towards a Type 2 immune profile. A similar reduction was not observed in T1DM patients (Fig. 4D ). No differences were observed when Type 1/Type 2 T cell ratios were compared between control and T1DM patients. Exclusion of data from the two T1DM patients who subsequently became preeclamptic did not alter outcomes from these analyses. That is, Type 1/Type 2 ratios were stable for all lymphocyte subsets of the T1DM women. This suggests that T1DM, whether or not it is [30] . This could represent a common immune pathway, or potential mechanism promoting diabetogenic risk for preeclampsia, but requires further study.
Expression of adhesion and chemokine receptors across control and T1DM pregnancies and postpartum
The percentages of each lymphocyte subset expressing ITGA4 and SELL, and CXCR3 and CXCR4 were examined during pregnancy and postpartum. These data are summarized in S4 Fig. 7A ). This finding may suggest that in T1DM, the need for high levels of uNK cell functions persists at the maternal fetal interface longer (into 3 rd trimester) than in normal pregnancies and that a compensatory response has occurred to sustain CD56 bright NK cell extravasation. The timing of this difference also coincides with onset rapid fetal growth and of clinical recognition of preeclampsia and may reflect a lymphocyte phenotype induced by tissue-specific endothelial cell stress [30, [40] [41] [42] . 
Outcomes of T1DM in Circulating Lymphocytes during Pregnancy
The analysis of homing receptors expressed by Type 1 NKT cells showed that T1DM patients, but not control patients, vary during pregnancy. In T1DM patients, Type 1 NKT cells expressing ITGA4 were significantly reduced at postpartum (23. 23.2%±11.4), fewer Type 1 NKT cells expressing ITGA4 were measured in T1DM than control patients (control vs. T1DM respectively, P<0.05; Fig. 7B ). Exclusion of the two preeclamptic Outcomes of T1DM in Circulating Lymphocytes during Pregnancy patients from these analyses annulled the statistical differences. ITGA4 involvement in NKT cell homing potential for decidua is compatible with its higher expression in peripheral NKT cells of fertile versus infertile women [43] . Since no control patients developed preeclampsia, the implications of the altered expression of ITGA4 on Type 1 NKT cells in preeclampsia remains unclear.
Adoptive transfer experiments in mice [18] and analyses of human decidua [44] supports the conclusion that decidual lymphocytes arise from cells that home from the circulation. Further, in vitro differentiation of CD56 + blood NK cells into decidua-like CD16 -CD56 bright is reported [45] . However, endometrial hematopoietic progenitor cells (CD34 + CD45 + ) are also described in first trimester [17] . Thus, at least in early decidua, hematopoietic progenitor cells may contribute significantly to the gains in decidual NK cells, as predicted by their capacity for in vitro differentiation [17] . . This is similar to the estimated half-life of peripheral mouse NK cells [47, 48] . The main differences between our normal and T1DM study participants were found in 2 nd trimester, a time that may represent a secondary wave of leukocyte recruitment to the decidua from the circulation. The enrichment of different lymphocyte subsets (functionally and phenotypically) in decidua as pregnancy progresses is widely accepted. The data presented here add to understanding that over the course of normal pregnancy, the potential for tissue recruitment of circulating NK and T cells is dynamic and differs between lymphocyte subsets, with CD56 bright NK cells showing the highest and most dynamic expression of key receptors. We also show that a disease process, T1DM, depresses these receptor changes in a manner that might reduce important lymphocyte-based functions at the maternal-fetal interface.
Cytokines, chemokines and growth factors across control and T1DM pregnancies and postpartum 11 analytes (IL1B, IL2, IL5, IL6, IL8, IL10, IL13, IL15 , CSF2, VEGF and TNF) were undetectable in all samples tested. 10 analytes (IL9, IL12, IL17, FGF, IFNG, CCL3, CCL11, ILR1A, IL4 and PDGF) were sporadically detected in control and T1DM patients; cytokines tended to be less frequently detected in T1DM patients (Fig. 8) (Table 2 ). IL7 supports the differentiation and functions of multiple lymphoid and myeloid lineages [49, 50] ; including CD56 bright NK cells [51] , but knowledge concerning the role of IL7 during pregnancy is limited. However, a potential role for IL7 in induction of expression of CXCR3, CXCR4 and other integrins is reported in T lymphocytes [52] [53] [54] . This may be linked with the increased number of homing receptors expressed by blood CD56 bright NK cells in control, but not in T1DM patients. Larger number of patients and in vitro studies would be required to address this possible mechanism. CSF3 was also up regulated in control patients at 2 nd trimester, but not in T1DM (Table 2) . Although more frequently studied during labor [55] , CSF3 is reported to promote Type 2 cytokine secretion, activate T regulatory cells [56] , and stimulate endometrial vascular remodeling ex-vivo [57] . These functions could aid in coordination of the shift to Type 2 immune state observed in control patients in 2 nd trimester, which is not seen in T1DM patients. Confirmatory and functional studies are necessary to establish the importance and mechanistic roles for CSF3 deficiency in T1DM pregnancies. The representative scheme demonstrates 10 cytokines that were sporadically detected in the plasma from 13 patients: controls (C0) and T1DM (S0). Three cytokines were detected in a frequency higher than 40% (IL1RA, IL4 and PGFFB) while seven cytokines were detected in a frequency lower than 40% (IL9, IL12, IL17, FGF, IFNG, CCL3 and CCL11). The low frequency of cytokines/chemokines/growth factors detection is evident in T1DM patients. The symbol Ø identifies samples that were not available for the experiment.
doi:10.1371/journal.pone.0119526.g008 Table 2 . Cytokine concentrations in control and T1DM plasma across pregnancy and postpartum. Supporting Information S1 
